Skip to content

SHAIVALADYA GEL IN ACUTE FISSURE IN ANO

RANDOMISED CONTROLLED CLINICAL TRIAL OF SHAIVALADYA GEL & LIGNOCAINE JELLY 2% APPLICATION IN THE MANAGEMENT OF PARIKARTIKA WITH SPECIAL REFERENCE TO ACUTE FISSURE IN ANO - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055627
Enrollment
40
Registered
2023-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K600- Acute anal fissure

Interventions

None listed

Sponsors

DR VIKASKUMAR PATEL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from Parikartika Acute fissure in ano with symptoms of Painful defecation burning sensation bleeding per rectum ie stools streaked with blood constipation spasm of the sphincter Patient having solitary and multiple anal fissure Pregnant women and Post partum patients Patient within the age group of 18 to 70 years of age Patients will be selected irrespective of cast and religion gender habitat occupation and socio economic status

Exclusion criteria

Exclusion criteria: Chronic fissure in ano Patients having parikartika Fissure in Ano secondary to known case of Ulcerative colitis Crohns disease Syphilis and Tuberculosis Malignancy will be excluded Patient below 18 years of age and above 70 years Patient with infective wound at anal region HIV and hepatitis B Uncontrolled diabetes mellitus

Design outcomes

Primary

MeasureTime frame
WILL SUBSIDE THE SYMPTOMS OF ACUTE FISSURE IN ANO IE PAIN BURNING SPHINCTER SPASMTimepoint: 10 DAYS

Secondary

MeasureTime frame
will cure the acute fissure in anoTimepoint: 10 DAYS

Countries

India

Contacts

Public ContactDR PARIKSHIT SHIRODE

PARUL INSTITUTE OF AYURVED

parikshit.shirode260038@paruluniversity.ac.in9175882746

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026